Sun Pharmaceutical Industries, INC.

Generic Pharmaceutical Company

Based in NY

🤖

AI Overview

With $1.9M in lobbying spend across 32 quarterly filings, Sun Pharmaceutical Industries, INC is a significant lobbying presence. Their lobbying covers 1 issue area. Active from 2018 to 2025.

$1.9M
Total Spend
8
Years Active
1
Firms Hired
8
Lobbyists Deployed
1
Issues Lobbied

Spending Trend

View as table
YearLobbying Spend
2018$240K
2019$240K
2020$240K
2021$240K
2022$240K
2023$240K
2024$240K
2025$240K

Issues Lobbied

Lobbying Firms

Lobbyists

What They Lobby About

These are actual descriptions from their quarterly lobbying disclosure filings, summarizing what they lobbied Congress and federal agencies about.Issue areas: Pharmacy

  • S. 974- CREATES Act of 2017
  • S. 974- CREATES Act of 2017, H.R.2212 - CREATES Act of 2017, Issues relating to biodefense
  • H.R. 965- CREATES Act of 2019, S. 340 - CREATES Act of 2019, Issues relating to biodefense, H.R. 1499- Protecting Consumer Access to Generic Drugs Act of 2019
  • S. 340 - CREATES Act of 2019, Issues relating to biodefense, S. 64 - Preserve Access to Affordable Generics and Biosimilars Act

Related Analysis

Related Investigations

Similar Clients

Explore More

Data Sources: Senate LDA Filings

Last updated: February 2026

This site is an independent journalism project. Analysis and editorial content are not affiliated with or endorsed by any government agency.